ArticleJournal for immunotherapy of cancer2025

Oncolytic VSV-IL-2 has enhanced anticancer vaccination adjuvant abilities.

Victor Mullins-Dansereau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.